Medical Health & Life Science Research News

New report examines the 0.2+% competent cells market growth during the 2017–2022

Top-down and bottom-up approaches were used to estimate and validate the size of the competent cells market and to estimate the size of various other dependent submarkets.

- Agency -.

The global competent cells market is projected to reach USD 2.22 billion by 2022 from USD 1.37 billion in 2017, at a CAGR of 10.2%.  

Get Sample Copy [email protected] www.rnrmarketresearch.com/contacts…le?rname=1142771

Advancements in molecular cloning research due to the emergence of new technologies and the growing commercial demand for molecular cloned products and recombinant proteins are some the key factors driving the growth of this market. On the other hand, increasing market consolidation creating strong entry barriers and high cost of competent cells kits are restraining the growth of this market.

The electro competent cells segment is expected to register the highest CAGR during the forecast period

The competent cells market is classified on the basis of type into chemically competent cells and electro competent cells.

- Agency -.

Electro competent cells are expected to grow at the highest CAGR during the forecast period. Electro competent cells offer high transformation efficiencies, making them suitable for many molecular biology applications such as the generation of cDNA libraries or constructing gene banks.

Report on Competent cells Market 2017-2022 Spreads Across 169 Pages Profiling 25 Companies and Supported with 101 Tables And 39 Figures Available at www.rnrmarketresearch.com/contacts…nt?rname=1142771

*Top 25 Companies Analyzed for This Studies are - Key players operating in the competent cells market include Merck KGaA (Germany) Promega Corporation (U.S.), Thermo Fisher Scientific, Inc. (U.S), New England Biolabs (U.S.), Takara Bio (Japan), Agilent Technologies (U.S.), Lucigen (Epicenter) (Illumina) (U.S.), QIAGEN N.V.

(Germany), OriGene Technologies (U.S.), Bioline (U.K.), Zymo Research (U.S.), Beijing TransGen Biotech Co., Ltd. (China), Source BioScience (U.K.), IBA GmBH (Germany), Genewiz (U.S.), BioDynamics Laboratory, Inc.

(Japan), GCC Biotech (India), SMOBIO Technology (Taiwan), GeneScript Corporation (U.S.), Bio-Rad Laboratories (U.S.), Life Technologies (India) Pvt. Ltd., Cell Applications, Inc. (U.S.), Delphi Genetics (Belgium), Scarab Genomics, LLC (U.S.), and Yeastern Biotech Co., Ltd.

(Taiwan).

Target Audience for this Report:

  • Competent cell manufacturers
  • Research instrument manufacturers
  • Competent cell distributors
  • Various research and consulting companies
  • Research laboratories and research institutes
  • Universities and CROs

Key point from table of content 

6 Competent Cells Market, By Type
6.1 Introduction
6.2 Chemically Competent Cells
6.3 Electrocompetent Cells 

7 Competent Cells Market, By Application
7.1 Introduction
7.2 Cloning
7.2.1 Subcloning & Routine Cloning
7.2.2 Phage Display Library Construction

8 Competent Cells Market, By End User
8.1 Introduction
8.2 Academic Research Institutes
8.3 Pharmaceutical & Biotechnology Companies

Browse Here for full Report with TOC: www.rnrmarketresearch.com/competen…rket-report.html

News From

RnR Market Research - Market Research and Competitive Analysis ReportsRnR Market Research
Category: Market Research Publishers and RetailersCompany profile: RnRMarketResearch.com is an online database of market research reports offers in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.